These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 19126674)

  • 1. Combinatorial probabilistic chromatin interactions produce transcriptional heterogeneity.
    Voss TC; Schiltz RL; Sung MH; Johnson TA; John S; Hager GL
    J Cell Sci; 2009 Feb; 122(Pt 3):345-56. PubMed ID: 19126674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-cell analysis of glucocorticoid receptor action reveals that stochastic post-chromatin association mechanisms regulate ligand-specific transcription.
    Voss TC; John S; Hager GL
    Mol Endocrinol; 2006 Nov; 20(11):2641-55. PubMed ID: 16873444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear factor 1 is required for both hormone-dependent chromatin remodeling and transcriptional activation of the mouse mammary tumor virus promoter.
    Hebbar PB; Archer TK
    Mol Cell Biol; 2003 Feb; 23(3):887-98. PubMed ID: 12529394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of chromatin remodeling and transcriptional activation of the mouse mammary tumor virus promoter by the androgen and glucocorticoid receptor.
    List HJ; Lozano C; Lu J; Danielsen M; Wellstein A; Riegel AT
    Exp Cell Res; 1999 Aug; 250(2):414-22. PubMed ID: 10413595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reconstitution of glucocorticoid receptor-dependent transcription in vivo.
    Trotter KW; Archer TK
    Mol Cell Biol; 2004 Apr; 24(8):3347-58. PubMed ID: 15060156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective binding of steroid hormone receptors to octamer transcription factors determines transcriptional synergism at the mouse mammary tumor virus promoter.
    Préfontaine GG; Walther R; Giffin W; Lemieux ME; Pope L; Haché RJ
    J Biol Chem; 1999 Sep; 274(38):26713-9. PubMed ID: 10480874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mouse mammary tumor virus promoter adopts distinct chromatin structures in human breast cancer cells with and without glucocorticoid receptor.
    Kinyamu HK; Fryer CJ; Horwitz KB; Archer TK
    J Biol Chem; 2000 Jun; 275(26):20061-8. PubMed ID: 10751396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of hormone antagonists on chromatin remodeling and transcription factor binding to the mouse mammary tumor virus promoter in vivo.
    Mymryk JS; Archer TK
    Mol Endocrinol; 1995 Dec; 9(12):1825-34. PubMed ID: 8614418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid hormone receptor status defines the MMTV promoter chromatin structure in vivo.
    Archer TK; Fryer CJ; Lee HL; Zaniewski E; Liang T; Mymryk JS
    J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):421-9. PubMed ID: 7626491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromatin-dependent regulation of the MMTV promoter by cAMP signaling is mediated through distinct pathways.
    Mulholland NM; Snyder SK; Kolla SS; Smith CL
    Exp Cell Res; 2003 Jul; 287(2):361-73. PubMed ID: 12837291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large-scale chromatin decondensation and recondensation regulated by transcription from a natural promoter.
    Müller WG; Walker D; Hager GL; McNally JG
    J Cell Biol; 2001 Jul; 154(1):33-48. PubMed ID: 11448988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct, genome-wide, gene-specific selectivity patterns of four glucocorticoid receptor coregulators.
    Wu DY; Ou CY; Chodankar R; Siegmund KD; Stallcup MR
    Nucl Recept Signal; 2014; 12():e002. PubMed ID: 25422592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromatin-mediated restriction of nuclear factor 1/CTF binding in a repressed and hormone-activated promoter in vivo.
    Belikov S; Astrand C; Holmqvist PH; Wrange O
    Mol Cell Biol; 2004 Apr; 24(7):3036-47. PubMed ID: 15024090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic action of GA-binding protein and glucocorticoid receptor in transcription from the mouse mammary tumor virus promoter.
    Aurrekoetxea-Hernández K; Buetti E
    J Virol; 2000 Jun; 74(11):4988-98. PubMed ID: 10799572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid receptor-mediated chromatin remodeling in vivo.
    Deroo BJ; Archer TK
    Oncogene; 2001 May; 20(24):3039-46. PubMed ID: 11420719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A ligand binding domain mutation in the mouse glucocorticoid receptor functionally links chromatin remodeling and transcription initiation.
    Sheldon LA; Smith CL; Bodwell JE; Munck AU; Hager GL
    Mol Cell Biol; 1999 Dec; 19(12):8146-57. PubMed ID: 10567540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid hormone-induced receptor localization to the chromatin fibers formed on injected DNA in Xenopus oocytes.
    Gelius B; Wrange O
    Exp Cell Res; 2001 May; 265(2):319-28. PubMed ID: 11302698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid receptor binding to chromatin is selectively controlled by the coregulator Hic-5 and chromatin remodeling enzymes.
    Lee BH; Stallcup MR
    J Biol Chem; 2017 Jun; 292(22):9320-9334. PubMed ID: 28381557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The HSA domain of BRG1 mediates critical interactions required for glucocorticoid receptor-dependent transcriptional activation in vivo.
    Trotter KW; Fan HY; Ivey ML; Kingston RE; Archer TK
    Mol Cell Biol; 2008 Feb; 28(4):1413-26. PubMed ID: 18086889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different chromatin and DNA sequence characteristics define glucocorticoid receptor binding sites that are blocked or not blocked by coregulator Hic-5.
    Lee BH; Stallcup MR
    PLoS One; 2018; 13(5):e0196965. PubMed ID: 29738565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.